# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-005202
Filing Date
2022-03-31
Accepted
2022-03-31 16:11:30
Documents
96
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | sbtx-20211231.htm iXBRL | 10-K | 2667506
2 | EX-10.1 | sbtx-ex10_1.htm | EX-10.1 | 235535
3 | EX-10.15 | sbtx-ex10_15.htm | EX-10.15 | 59104
4 | EX-23.1 | sbtx-ex23_1.htm | EX-23.1 | 6120
5 | EX-31.1 | sbtx-ex31_1.htm | EX-31.1 | 19990
6 | EX-31.2 | sbtx-ex31_2.htm | EX-31.2 | 19986
7 | EX-32.1 | sbtx-ex32_1.htm | EX-32.1 | 23940
8 | GRAPHIC | img42437169_0.jpg | GRAPHIC | 2710
9 | GRAPHIC | img42437169_1.jpg | GRAPHIC | 1187
10 | GRAPHIC | img238320182_0.jpg | GRAPHIC | 63489
11 | GRAPHIC | img238320182_1.jpg | GRAPHIC | 31534
12 | GRAPHIC | img238320182_2.jpg | GRAPHIC | 23090
13 | GRAPHIC | img238320182_3.jpg | GRAPHIC | 20519
14 | GRAPHIC | img238320182_4.jpg | GRAPHIC | 9616
15 | GRAPHIC | img238320182_5.jpg | GRAPHIC | 11033
16 | GRAPHIC | img238320182_6.jpg | GRAPHIC | 13633
17 | GRAPHIC | img238320182_7.jpg | GRAPHIC | 11524
18 | GRAPHIC | img238320182_8.jpg | GRAPHIC | 239601
19 | GRAPHIC | img238320182_9.jpg | GRAPHIC | 31254
20 | GRAPHIC | img238320182_10.jpg | GRAPHIC | 29100
21 | GRAPHIC | img238320182_11.jpg | GRAPHIC | 14332
22 | GRAPHIC | img238320182_12.jpg | GRAPHIC | 12786
23 | GRAPHIC | img238320182_13.jpg | GRAPHIC | 22957
24 | GRAPHIC | img238320182_14.jpg | GRAPHIC | 47760
25 | GRAPHIC | img238320182_15.jpg | GRAPHIC | 14531
26 | GRAPHIC | img238320182_16.jpg | GRAPHIC | 24800
27 | GRAPHIC | img238320182_17.jpg | GRAPHIC | 63489
| Complete submission text file | 0000950170-22-005202.txt |  | 10110991

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
28 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | sbtx-20211231_lab.xml | EX-101.LAB | 412978
29 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | sbtx-20211231_cal.xml | EX-101.CAL | 41862
30 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | sbtx-20211231_pre.xml | EX-101.PRE | 313395
31 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | sbtx-20211231.xsd | EX-101.SCH | 49896
32 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | sbtx-20211231_def.xml | EX-101.DEF | 169167
90 | EXTRACTED XBRL INSTANCE DOCUMENT | sbtx-20211231_htm.xml | XML | 1196334

Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39756 | Film No.: 22792603
SIC: 2834 Pharmaceutical Preparations